Cytotoxicity of resorcinol under short-and long-term exposure in vitro

International Journal of Occupational Safety and Ergonomics

Volumn 10, Issue 2, 2004, Pages 147-156

  Skowroń, Jolanta ^a   Zapór, Lidia ^a  

^a CENTRAL INSTITUTE FOR LABOUR PROTECTION NATIONAL RESEARCH INSTITUTE   (Poland)

Author keywords

Bioreactor; In vitro methods; Long term toxicity; Resorcinol; Short term toxicity

Indexed keywords

RESORCINOL; RESORCINOL DERIVATIVE;

ANIMAL; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; FIBROBLAST; IN VITRO STUDY; MITOCHONDRION; MOUSE; PATHOLOGY; TIME;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; MICE; MITOCHONDRIA; RESORCINOLS; TIME FACTORS;

EID: 3242768535     PISSN: 10803548     EISSN: None     Source Type: Journal    
DOI: 10.1080/10803548.2004.11076603     Document Type: Article

References (34)

1. Seibert H, Gülden M, Kolossa M, Schepers G. Evaluation of the relevance of selected in vitro toxicity test systems for acute systemic toxicity. ATLA 1992;20: 240–5.
2. Balls M, Fentem JH. The use of basal cytotoxicity and target organ toxicity tests in hazard identification and risk assessment. ATLA 1992;20: 386–8.
3. Seibert H, Gülden M, Voss J-U. Comparative cell toxicology: the basis for in vitro toxicity testing. ATLA 1994;22: 168–74.
4. American Conference of Governmental Industrial Hygienists (ACGIH).Documentation of the TLVs® and BEIs® with other worldwide occupational exposure values [CD-ROM]. Cincinnati, OH, USA: ACGIH; 2002.
5. TOXLINE®, CCINFOdisc. [CD-ROM]. Hamilton Ont., Canada: Canadian Centre for Occupational Health and Safety, 2002.
6. Sapota A, Ligocka D. Rezorcyna. Principles and Methods of Assessing the Working Environment 2001;1(27): 127–45.
7. Tennant JA. Evaluation of trypan blue technique for determination of cell viability. Transplantation 1964;12: 285–692.
8. Ekwall B. Correlation between cytotoxicity in vitro and LD50 values. Acta Pharmacol Toxicol (Copenh) 1983;52(Suppl. II): 80–99.
9. INVITTOX protocol No. 64. The neutral red cytotoxicity assay. The ERGATT/FRAME data bank of in vitro techniques in toxicology. Nottingham, UK: INVITTOX; 1992.
10. INVITTOX protocol No. 17. MTT assay. The ERGATT/FRAME data bank of in vitro techniques in toxicology. Nottingham, UK: INVITTOX; 1990.
11. INVITTOX protocol No. 3b. The frame cytotoxicity test (kenacid blue). The ERGATT/FRAME data bank of in vitro techniques in toxicology. Nottingham, UK: INVITTOX; 1992.
12. Hockley K, Baxter D. Use of the 3T3 cell-neutral red uptake assay for irritants as an alternative to the rabbit (Draize) test. Fd Chem Toxic 1986;24(6/7): 473–5.
13. Knox P, Uphill PF, Fry JR, Benford J, Balls M. The FRAME multicentre project on in vitro cytotoxicology. Fd Chem Toxic 1986;24: 457–63.
14. Zapór L. Toxicity of some phenolic derivatives—in vitro studies. JOSE. In press.
15. Burch W, Ellinger A, Torok L, Parzafall W, Coulibaly S, Hochegger K, Schorkhuber M, Patrik G, Marian B, Walker R, Sikorska R, Schulte-Hermann L. In Vitro studies on subtypes and regulation of active cell death. Toxicol in Vitro 1997;11: 579–88.
16. Cornelis M, Dupont C, Wepierre J. In vitro cytotoxicity tests on cultured human skin fibroblasts to predict the irritation potential of surfactants. ATLA 1991;19(3): 324–36.
17. Davila JC, Rodriquez RJ, Melchert RB, Acosta D. Predictive value of in vitro model systems in toxicology. Annu Rev Pharmacol Toxicol 1998; 63–96.
18. Jain PT, Fitzpatrick MJ, Phelps PC, Berezesky IK, Trump BF. Studies of skin toxicity in vitro: dose-response studies on JB6 cells. Toxicol Pathol 1992;20: 394–404.
19. Ruppova K, Urbancikova M, Wsolowa L, Slamenova D. Apoptosis versus cytotoxicity in HeLa cells exposed to paracetamol. ATLA 1999;27(3): 403–12.
20. Clothier RH, Hulme L, Ahmed AB, Reeves HL, Smith M, Balls M. In vitro cytotoxicity of 150 chemicals to 3T3-L1 cells, assessed by the FRAME kenacid blue method. ATLA 1988;16: 84–95.
21. Riddell RJ, Panacer DS. Wilde SM, Clothier RH, Balls M. The importance of exposure period and cell type in in vitro cytotoxicity tests. ATLA 1986;14: 86–92.
22. Frazier JM. Multiple endpoint measurements to evaluate the intrinsic cellular toxicity of chemicals. In Vitro 1990;3:349.
23. Halle W, Spielmann H. Two procedures for the prediction of acute toxicity (LD50) from cytotoxicity data. ATLA 1992;20(1): 40–9.
24. Shaw AJ. Defining cell viability and cytotoxicity. ATLA 1994;22(2): 124–6.
25. Borenfreund E, Babich H, Martin-Alguacil N. (1990). Comparison of two in vitro cytotoxicity assays: the neutral red (NRU) and tetrazolium MTT tests. Toxicol in Vitro 1990;2:1–6
26. Walum E, Balls M, Bianchi V, Blaauboer B, Bolcsfoldi G, Guillouzo A, Moore GA, Odland L, Reinhardt Ch, Spielmann H. ECITTS: An integrated approach to the application of in vitro test systems to the hazard assessment of chemicals. ATLA 1992;20: 406–28.
27. Chiba K, Kawakami K, Tohyama K. Simultaneous evaluation of cell viability by neutral red, MTT and crystal violet staining assays of the same cells. Toxicol in Vitro 1998;12: 251–8.
28. Vian L, Vincent J, Maurin J, Fabre I, Giroux J, Cano JP. Comparison of three cytotoxicity assays for estimating surfactant ocular irritation. Toxicol in Vitro 1995;9: 185–90.
29. Waterfield CJ, Delaney J, Kerai MDJ, Timbrell JA. Correlation between in vivo and in vitro effects of toxic compounds: studies with hydrazine. Toxicol in Vitro 1997;11: 217–27.
30. Clothier RH, Atkinson KA, Garle MJ, Ward RK, Willshaw A. The development and evaluation of in vitro tests by the FRAME Alternatives Laboratory. ATLA 1995;23: 75–90.
31. Combes RD. Summary of discussion: in vitro models for investigation of chronic toxicity and reversibility. Toxicol in Vitro 1999;13: 853–7.
32. Hanley AB, McBride J, Oehlschlager S, Opara E. Use of flow cell bioreactor as a chronic toxicity model system. Toxicol in Vitro 1999;13: 847–51.
33. Skowron J, Zapór L. Ocena działania cytotoksycznego chlorku benzalkonium w warunkach narażenia długotrwałego in vitro w bioreaktorze INTEGRA CL 6-WELL. Bromatologia i Chemia Toksykologiczna 2002;XXXV(2): 179–85.
34. Calabrese EJ, Baldwin LA. Hormesis: a generalizable and unifying hypothesis. Crit Rev Toxicol 2001;31(4/5): 353–425.JOSE 2004, Vol. 10, No. 2